Mutual of America Capital Management LLC cut its holdings in Exponent, Inc. (NASDAQ:EXPO – Free Report) by 3.8% in the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 29,012 shares of the business services provider’s stock after selling 1,153 shares during the quarter. Mutual of America Capital Management LLC owned about 0.06% of Exponent worth $2,760,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. GAMMA Investing LLC boosted its position in Exponent by 67.7% in the second quarter. GAMMA Investing LLC now owns 379 shares of the business services provider’s stock valued at $36,000 after buying an additional 153 shares during the last quarter. Benjamin F. Edwards & Company Inc. grew its holdings in Exponent by 866.0% during the first quarter. Benjamin F. Edwards & Company Inc. now owns 512 shares of the business services provider’s stock worth $42,000 after acquiring an additional 459 shares during the period. Whittier Trust Co. of Nevada Inc. raised its position in Exponent by 166.5% during the second quarter. Whittier Trust Co. of Nevada Inc. now owns 517 shares of the business services provider’s stock valued at $49,000 after acquiring an additional 323 shares in the last quarter. Janiczek Wealth Management LLC lifted its holdings in Exponent by 293.7% in the first quarter. Janiczek Wealth Management LLC now owns 626 shares of the business services provider’s stock valued at $52,000 after acquiring an additional 467 shares during the period. Finally, YHB Investment Advisors Inc. purchased a new stake in Exponent in the 1st quarter worth approximately $75,000. 92.37% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In related news, VP John Pye sold 3,956 shares of the company’s stock in a transaction dated Tuesday, July 30th. The shares were sold at an average price of $105.00, for a total transaction of $415,380.00. Following the completion of the transaction, the vice president now owns 28,422 shares in the company, valued at approximately $2,984,310. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Company insiders own 2.10% of the company’s stock.
Exponent Stock Up 1.4 %
Exponent (NASDAQ:EXPO – Get Free Report) last announced its earnings results on Thursday, July 25th. The business services provider reported $0.57 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.07. Exponent had a return on equity of 28.39% and a net margin of 19.35%. The business had revenue of $132.43 million during the quarter, compared to the consensus estimate of $130.83 million. During the same period in the prior year, the company posted $0.50 EPS. The business’s quarterly revenue was up 2.1% on a year-over-year basis. On average, sell-side analysts expect that Exponent, Inc. will post 2.04 EPS for the current year.
Exponent Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, September 20th. Shareholders of record on Friday, September 6th were issued a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a yield of 0.99%. The ex-dividend date was Friday, September 6th. Exponent’s payout ratio is 56.57%.
Analyst Upgrades and Downgrades
Separately, Truist Financial restated a “buy” rating and set a $120.00 price target (up previously from $100.00) on shares of Exponent in a research report on Friday, July 26th.
Check Out Our Latest Report on EXPO
Exponent Company Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
See Also
- Five stocks we like better than Exponent
- What Are Dividend Challengers?
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Buy P&G Now, Before It Sets A New All-Time High
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- How Technical Indicators Can Help You Find Oversold Stocks
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO – Free Report).
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.